Targeting nuclear receptor corepressors for reversible male contraception
Proceedings of the National Academy of Sciences · 27.02.2024 · 121 (9)
DOI: 10.1073/pnas.2320129121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.02.2024. Verfasst von Suk-Hyun Hong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Repressor Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NOMIS Stiftung, HHS | National Institutes of Health.
Abstract (Originalsprache)
Despite numerous female contraceptive options, nearly half of all pregnancies are unintended. Family planning choices for men are currently limited to unreliable condoms and invasive vasectomies with questionable reversibility. Here, we report the development of an oral contraceptive approach based on transcriptional disruption of cyclical gene expression patterns during spermatogenesis. Spermatogenesis involves a continuous series of self-renewal and differentiation programs of spermatogonial stem cells (SSCs) that is regulated by retinoic acid (RA)–dependent activation of receptors (RARs), which control target gene expression through association with corepressor proteins. We have found that the interaction between RAR and the corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT) is essential for spermatogenesis. In a genetically engineered mouse model that negates SMRT-RAR binding (SMRT mRID mice), the synchronized, cyclic expression of RAR-dependent genes along the seminiferous tubules is disrupted. Notably, the presence of an RA-resistant SSC population that survives RAR de-repression suggests that the infertility attributed to the loss of SMRT-mediated repression is reversible. Supporting this notion, we show that inhibiting the action of the SMRT complex with chronic, low-dose oral administration of a histone deacetylase inhibitor reversibly blocks spermatogenesis and fertility without affecting libido. This demonstration validates pharmacologic targeting of the SMRT repressor complex for non-hormonal male contraception.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037.
- Department of Nutritional Sciences and Toxicology, The University of California, Berkeley, CA 94720.
- Department of Biological Chemistry, Center for Epigenetics and Metabolism, U1233 INSERM, University of California, Irvine, CA 92697.
- Reproductive Biology Group, Division of Developmental Biology, Department of Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands.
- Storr Liver Centre, The Westmead Institute for Medical Research and Sydney Medical School, University of Sydney, Westmead, NSW 2145, Australia.
ORCID-Profile: Annette R Atkins, Ruth T Yu, Joseph L Napoli, Dirk G de Rooij, Christopher Liddle, Michael Downes, Ronald M Evans
Förderung
- NCI NIH HHS
- NOMIS Stiftung
- HHS | National Institutes of Health
- HHS | NIH | National Cancer Institute
- March of Dimes Foundation
Zitieren
APA
Hong, S. H., Castro, G., Wang, D., Nofsinger, R., Kane, M., Folias, A., Atkins, A. R., Yu, R. T., Napoli, J. L., Sassone-Corsi, P., de Rooij, D. G., Liddle, C., Downes, M., & Evans, R. M. (2024). Targeting nuclear receptor corepressors for reversible male contraception. Proceedings of the National Academy of Sciences, 121(9). https://doi.org/10.1073/pnas.2320129121
Vancouver
Hong SH, Castro G, Wang D, Nofsinger R, Kane M, Folias A, et al. Targeting nuclear receptor corepressors for reversible male contraception. Proceedings of the National Academy of Sciences. 2024;121(9). doi:10.1073/pnas.2320129121
BibTeX
@article{Hong2024,
author = {Hong, Suk-Hyun and Castro, Glenda and Wang, Dan and Nofsinger, Russell and Kane, Maureen and Folias, Alexandra and Atkins, Annette R and Yu, Ruth T and Napoli, Joseph L and Sassone-Corsi, Paolo and de Rooij, Dirk G and Liddle, Christopher and Downes, Michael and Evans, Ronald M},
title = {Targeting nuclear receptor corepressors for reversible male contraception},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {9},
doi = {10.1073/pnas.2320129121}
}
EUVIMED